About Sandstone Diagnostics
Sandstone Diagnostics is a company based in Pleasanton (United States) founded in 2012 by Ulrich Schaff and Greg Sommer. It operates as a B2B. Sandstone Diagnostics has raised $11.97 million across 9 funding rounds from investors including LabCorp, NIH and HHS. Sandstone Diagnostics operates in a competitive market with competitors including Exseed Health, Human Biogenesis, Spermosens, Bonraybio and neoMimix, among others.
- Headquarter Pleasanton, United States
- Founders Ulrich Schaff, Greg Sommer
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.97 M (USD)
in 9 rounds
-
Latest Funding Round
$2.42 M (USD), Series A
May 10, 2019
-
Investors
LabCorp
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Sandstone Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Sandstone Diagnostics
Sandstone Diagnostics has successfully raised a total of $11.97M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2.42 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sandstone Diagnostics
Sandstone Diagnostics has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include LabCorp, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Women-led startups are funded through stage-agnostic investments and angel networks.
|
Locked | Locked | Locked | |
|
Buyouts and growth equity investments are pursued across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Sandstone Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sandstone Diagnostics
Investment portfolio details for Sandstone Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sandstone Diagnostics
Detailed financials for Sandstone Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sandstone Diagnostics Comparisons
Peer comparison for Sandstone Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sandstone Diagnostics
Sandstone Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exseed Health, Human Biogenesis, Spermosens, Bonraybio and neoMimix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a home-based sperm test kit
|
|
| Locked | Locked | Locked |
Provider of reproductive health services and solutions
|
|
| Locked | Locked | Locked |
Spermosens is focused on developing male-factor infertility diagnostic devices.
|
|
| Locked | Locked | Locked |
Bonraybio is focused on developing reproductive health solutions.
|
|
| Locked | Locked | Locked |
A microfluidics device for sperm selection and sorting is developed.
|
Detailed competitors of Sandstone Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sandstone Diagnostics
Complete news archive for Sandstone Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandstone Diagnostics
Sandstone Diagnostics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Sandstone Diagnostics is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Sandstone Diagnostics is a funded company, having raised a total of $11.97M across 9 funding rounds to date.
Sandstone Diagnostics provides rapid tests for accurate sperm count diagnostics through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and fertility testing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sandstone Diagnostics's top competitors include Spermosens, Exseed Health and Swimcount.
Sandstone Diagnostics has 9 investors. Key investors include LabCorp, NIH, HHS, DPW Holdings, and Cavendish Impact Foundation.